Par Drugs and Chemicals Limited — Board Meeting, 14-02-2025: Outcome of Board Meeting

The Board of Directors of Par Drugs and Chemicals Limited has approved the unaudited financial results for the quarter and nine months ending December 31, 2024. The company reported total revenue of ₹2,165.29 crore, resulting in a profit of ₹57.80 crore for the quarter. The Board also authorized the Chairman and the CEO to sign the approved financial results. Additionally, they noted the investor grievances report and reviewed the Corporate Governance Report for the same period. Advertisements for the financial results will be published in major newspapers.